Circulating miRNAs as Promising Biomarkers to Evaluate ECMO Treatment Responses in ARDS Patients
Authors:
- Gennaro MartucciGMGennaro Martucci
- Antonio ArcadipaneAAAntonio Arcadipane
- Fabio TuzzolinoFTFabio Tuzzolino
- Giovanna OcchipintiGOGiovanna Occhipinti
- Giovanna PanarelloGPGiovanna Panarello
- Claudia CarcioneCCClaudia Carcione
- Alessandro BertaniABAlessandro Bertani
- Pier Giulio ConaldiPCPier Giulio Conaldi
- Vitale MiceliVMVitale Miceli
Open Access
Abstract
The use of extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome (ARDS) has increased in the last decade. However, mortality remains high, and the complexity of ECMO requires individualized treatment. There are some biomarkers to monitor progression and predict clinical outcomes of ARDS. This project aims to advance the management of ARDS patients treated with ECMO by exploring miRNA expression in whole blood. The analysis was conducted on two groups with different length of ECMO: Group A (longer runs) and group B (shorter runs). We analyzed miRNAs before ECMO cannulation, and at 7 and 14 days of ECMO support. Our results showed that in the group B patients, 11 deregulated miRNAs were identified, and showed an opposite trend of expression compared to the group A patients. In silico analysis revealed that these 11 miRNAs were related to processes involved in the pathogenesis and evolution of ARDS. This scenario could represent homeostatic mechanisms by which, in ECMO responsive patients, pathways activated during ARDS progression are switched-off. Circulating miRNAs could represent promising biomarkers to monitor the evolution of ARDS under ECMO support. Further studies may shed light on this topic to improve a personalized approach in such a complex setting of patients.Keywords
This publication has 57 references indexed in Scilit:
- Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort studyCritical Care, 2013
- Genome-Wide Analyses of Amphioxus MicroRNAs Reveal an Immune Regulation via miR-92d Targeting C3The Journal of Immunology, 2013
- Amplification of FRS2 and Activation of FGFR/FRS2 Signaling Pathway in High-Grade LiposarcomaCancer Research, 2013
- TGF-β-associated miR-27a inhibits dendritic cell-mediated differentiation of Th1 and Th17 cells by TAB3, p38 MAPK, MAP2K4 and MAP2K7Genes & Immunity, 2012
- Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAsEMBO Molecular Medicine, 2012
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionEuropean Heart Journal, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Deubiquitylation and regulation of the immune responseNature Reviews Immunology, 2008
- Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell lineCell Death & Differentiation, 2005
- Caspase-mediated activation of PAK2 during apoptosis: proteolytic kinase activation as a general mechanism of apoptotic signal transduction?Cell Death & Differentiation, 1998